Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Flurry Powders LLC currently manages a concentrated patent portfolio within the Biotechnology & Pharmaceuticals technology area. The prosecution activity is presently limited to 1 pending office action. This matter is being handled by a distinct examiner, CHANG, KYUNG SOOK, who is also identified as the busiest examiner for the company with 1 pending office action. The focus of the portfolio is highly specific, as evidenced by the involvement of only 1 distinct art unit and 1 distinct examiner.
For a practitioner, this indicates a narrow channel of interaction with the USPTO. The workload is entirely consolidated under CHANG, KYUNG SOOK, meaning the outcome of the current 1 pending office action will define the immediate success of the company's biotechnology filings. This streamlined structure suggests a specialized filing strategy. The presence of 1 distinct art unit implies that the technical subject matter is consistently categorized within a specific niche of biotechnology. Consequently, the relationship with the 1 assigned examiner is the primary factor in the company's current prosecution landscape.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHANG, KYUNG SOOK | 1 | 60.4% | +40.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18528153 | ENCAPSULATION OF LIPOPHILIC INGREDIENTS IN DISPERSIBLE SPRAY DRIED POWDERS SUITABLE FOR INHALATION | CHANG, KYUNG SOOK | 56d overdue |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18528153 | ENCAPSULATION OF LIPOPHILIC INGREDIENTS IN DISPERSIBLE SPRAY DRIED POWDERS SUITABLE FOR INHALATION | CHANG, KYUNG SOOK | 1613 | §103§112DP | Final Rejection | 56d overdue | Pending | Dec 04, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial